BIOXYTRAN, INC
For the period ended Dec 31, 2024. Filed Apr 3, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 3, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 3. Legal Proceedings
At present, there is no other pending litigation or proceeding involving any of our Directors, Officers or employees as to which indemnification is sought, nor are we aware of any threatened litigation or proceeding that may result in claims for indemnification.
The Company may become involved in certain legal proceedings and claims which arise in the normal course of business.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.